<DOC>
	<DOC>NCT00870038</DOC>
	<brief_summary>The investigators sought to discover which one of the following strategies is the safest for patients undergoing percutaneous coronary intervention: paclitaxel-coated balloon+Genous stent; Genous stent; drug eluting stent (paclitaxel).</brief_summary>
	<brief_title>To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study</brief_title>
	<detailed_description />
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Stable or unstable angina pectoris suitable to PCI of at least one coronary vessel Age &gt;18 years Recent (&lt;72 hours) acute myocardial infarction Creatinine clearance &lt;40 ml/min Allergy or hypersensitivity to at least two between: aspirin, clopidogrel, heparin, bivalirudin, paclitaxel, contrast media Life expectancy &lt;1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>PCI</keyword>
	<keyword>stent</keyword>
	<keyword>drug eluting stent</keyword>
	<keyword>reendothelialization</keyword>
	<keyword>restenosis</keyword>
	<keyword>Percutaneous Coronary Angioplasty</keyword>
</DOC>